Ako­rn’s bank­rupt­cy, re­calls bring a drug to treat lead poi­son­ing in­to short­age

A drug used to treat lead poi­son­ing is now in short sup­ply af­ter Ako­rn Phar­ma­ceu­ti­cals filed for bank­rupt­cy and many of its prod­ucts were re­called …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.